Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Surgery

Understanding MSL Subtypes and Patterns

At a Glance

Multiple Symmetric Lipomatosis (MSL) is classified into subtypes based on where fat deposits grow. Type I (Madelung Disease) mostly affects the neck and shoulders, increasing airway risks. Type II affects the trunk and hips, carrying higher metabolic risks. Knowing your subtype guides surgical planning and medical screening.

Doctors use classification systems to help “map” Multiple Symmetric Lipomatosis (MSL). While the disease looks different on everyone, these categories help your medical team predict how the disease might progress, what health risks you face, and how to plan for treatment.

As our understanding of the disease has grown, these systems have evolved from simple “Types” to more detailed frameworks.

The Traditional Enzi Classification

For many years, doctors used the Enzi Classification, which split MSL into two broad categories based on where the fat was located and who was most likely to have it.

  • Type I (Madelung Disease):

    • Appearance: Fat deposits are localized and prominent around the neck (the “Madelung collar”), nape of the neck, shoulders, and upper back (the “buffalo hump”) [1][2].
    • Demographics: Most commonly seen in middle-aged men with a history of chronic alcohol consumption [1][3].
    • Primary Risk: Because the fat is concentrated around the neck, there is a higher risk of the masses pressing on the airway or esophagus [4][5].
  • Type II (Launois-Bensaude Syndrome):

    • Appearance: The fat is more diffuse and spread out. It often involves the trunk, hips, and upper thighs, which can cause it to be mistaken for simple obesity [1][4].
    • Demographics: This type occurs in both men and women and typically has no association with alcohol use [1][4].
    • Primary Risk: While the airway is usually safe, Type II is often associated with more significant metabolic issues, like diabetes and high cholesterol [4][6].

Why New Systems Were Needed

While the Enzi system was a good start, researchers found that more than 50% of patients didn’t fit perfectly into Type I or Type II [7]. Some people had fat in their neck and their hips, while others had very specific patterns that didn’t match either group. This led to the development of a more detailed 5-type classification system.

  • Type I (a, b, and c): These represent variations of the neck and shoulder patterns. Type Ia is limited to the neck, while Ic might extend further down the arms or chest [7].
  • Type II: This remains the category for generalized fat distribution across the trunk and hips [7].
  • Type III: A newer category for fat that is primarily concentrated in the pelvic region and lower body [7].

Why Subtypes Matter for Your Care

Knowing your subtype is about more than just a label; it guides your “road map” for care:

  1. Surgical Planning: If you have Type I, surgeons prioritize removing fat from the neck to prevent it from infiltrating the “deep” spaces around your vocal cords or windpipe [8][5]. For Type II, surgery is often focused on improving mobility or reducing the weight of the masses on the torso.
  2. Functional Monitoring: Patients with Type I patterns are often screened early for obstructive sleep apnea (OSA) because the weight of the neck fat can collapse the airway during sleep [9][10].
  3. Metabolic Screening: While all MSL patients should have their blood sugar and liver function checked, certain subtypes are more strongly linked to metabolic syndrome and peripheral neuropathy [11][6].

By identifying your specific pattern, your doctor can tailor a screening schedule that watches for the complications most likely to affect you.

Common questions in this guide

What is the difference between MSL Type I and Type II?
Type I features fat deposits localized around the neck, shoulders, and upper back, sometimes forming a 'Madelung collar'. Type II involves fat that is more diffuse and spread across the trunk, hips, and upper thighs.
Why is knowing my MSL subtype important?
Your subtype helps doctors predict potential health risks and map out your care. For example, Type I carries a higher risk of airway problems that require monitoring, while Type II is more closely linked to metabolic issues like diabetes that need regular screening.
What is Madelung Disease?
Madelung Disease is another name for MSL Type I. It specifically refers to the pattern where fat deposits form a prominent collar around the neck and a 'buffalo hump' on the upper back.
Does MSL cause sleep apnea?
Yes, people with MSL Type I are at a higher risk for obstructive sleep apnea. The physical weight of the fat deposits around the neck can press on the airway and cause it to collapse during sleep.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my fat distribution, which of the five MSL subtypes (Ia, Ib, Ic, II, or III) do I most closely align with?
  2. 2.Does my subtype put me at a higher risk for airway obstruction or sleep apnea?
  3. 3.Is my fat distribution more consistent with the 'alcoholic' associated Type I or the 'non-alcoholic' Type II?
  4. 4.How does my specific subtype change your approach to surgery—for example, will you prioritize the neck area for functional reasons over aesthetic ones?
  5. 5.Because of my fat distribution, should I be more closely screened for specific metabolic issues like diabetes or liver disease?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (11)
  1. 1

    Do you know this syndrome? Type 2 benign symmetric lipomatosis (Launois-Bensaude).

    Esposito AC, Munhoz T, Abbade LP, Miot HA

    Anais brasileiros de dermatologia 2016; (91(6)):840-841 doi:10.1590/abd1806-4841.20164744.

    PMID: 28099616
  2. 2

    Madelung's disease - progressive, excessive, and symmetrical deposition of adipose tissue in the subcutaneous layer: case report and literature review.

    Szewc M, Sitarz R, Moroz N, et al.

    Diabetes, metabolic syndrome and obesity : targets and therapy 2018; (11()):819-825 doi:10.2147/DMSO.S181154.

    PMID: 30538518
  3. 3

    Shedding Light on Multiple Symmetric Lipomatosis: An Overlooked Syndrome in the Evaluation of Obesity.

    Saraiva M, Ferreira LMD, Carvalho R

    The American journal of case reports 2023; (24()):e941751 doi:10.12659/AJCR.941751.

    PMID: 38039195
  4. 4

    Madelung disease with postoperative priapism and multiple venous thromboses: case report and literature review.

    Guo L, Li W, Xu X, Xiao H

    Frontiers in cardiovascular medicine 2024; (11()):1449556 doi:10.3389/fcvm.2024.1449556.

    PMID: 39257843
  5. 5

    Multiple symmetric lipomatosis with secondary laryngeal obstruction: A case report.

    Cui Y, Cui X, Gao S, et al.

    Medicine 2020; (99(27)):e21014 doi:10.1097/MD.0000000000021014.

    PMID: 32629721
  6. 6

    MFN2-associated lipomatosis: Clinical spectrum and impact on adipose tissue.

    Capel E, Vatier C, Cervera P, et al.

    Journal of clinical lipidology 2018; (12(6)):1420-1435 doi:10.1016/j.jacl.2018.07.009.

    PMID: 30158064
  7. 7

    Multiple Symmetric Lipomatosis: New Classification System Based on the Largest German Patient Cohort.

    Schiltz D, Anker A, Ortner C, et al.

    Plastic and reconstructive surgery. Global open 2018; (6(4)):e1722 doi:10.1097/GOX.0000000000001722.

    PMID: 29876171
  8. 8

    Madelung's Disease: Lipectomy or Liposuction?

    Chen CY, Fang QQ, Wang XF, et al.

    BioMed research international 2018; (2018()):3975974 doi:10.1155/2018/3975974.

    PMID: 29682541
  9. 9

    A case of severe obstructive sleep apnoea in Madelung's disease treated by lateral pharyngoplasty.

    Pinto V, Morselli PG, Tassone D, Piccin O

    The Journal of laryngology and otology 2017; (131(9)):834-837 doi:10.1017/S0022215117001062.

    PMID: 28532519
  10. 10

    A case of Madelung's disease presenting with obstructive sleep apnea.

    Segsarnviriya C, Chirakalwasan N

    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2020; (16(9)):1603-1605 doi:10.5664/jcsm.8622.

    PMID: 32515345
  11. 11

    A case report of Multiple Symmetric Lipomatosis (MSL) in an East Asian Female.

    Jung K, Lee S

    BMC women's health 2020; (20(1)):200 doi:10.1186/s12905-020-01055-w.

    PMID: 32928192

This page explains MSL subtypes and fat distribution patterns for educational purposes only. Always consult your medical team to determine your specific classification and appropriate treatment plan.

Get notified when new evidence is published on Multiple symmetric lipomatosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.